Announcing a new publication for Acta Materia Medica journal. Agomelatine (AGO) is an antidepressant with limited clinical application due to its low bioavailability caused by poor water solubility, severe hepatic degradation, and poor intracerebral distribution.
Efficient intranasal delivery of agomelatine via micellar encapsulation
- Post author:
- Post published:May 6, 2024
- Post category:uncategorized